ARCHIVES

DCCR Merit Review Of Contracts Finds Most Perform Satisfactorily; 21 Phased Out Early

This article is from The Cancer Letter archive.

Vol. 05 No. 01 | January 5, 1979

Download PDF Visit The Full Archive

Related Articles

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

December 28, 2001

In Brief: Kennedy Seeing Comments On HAS Regulations; Shimkins History of Cancer Now Available

November 11, 1977

Higher Tobacco Tax Will Save Lives, Groups Tell Clinton, congress

January 22, 1993

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011